ASLAN Pharmaceuticals Limited logo
ASLAN Pharmaceuticals Limited ASLN

Annual report 2020
added 08-19-2023

report update icon

ASLAN Pharmaceuticals Limited Long Term Debt Current 2011-2026 | ASLN

Annual Long Term Debt Current ASLAN Pharmaceuticals Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 272 K 265 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
272 K 265 K 268 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.89 - $ 6.54 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.35 0.68 % $ 3.7 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 103.69 2.08 % $ 27.2 B germanyGermany
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.65 22.48 % $ 6.01 M israelIsrael
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.08 0.74 % $ 436 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 22.65 1.25 % $ 2.88 B usaUSA
Edesa Biotech Edesa Biotech
EDSA
19.9 K $ 16.23 2.08 % $ 51.9 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Athira Pharma Athira Pharma
ATHA
465 K - - $ 269 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.42 0.71 % $ 378 M britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Evogene Ltd. Evogene Ltd.
EVGN
716 K $ 0.79 4.79 % $ 27.9 M israelIsrael
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Exelixis Exelixis
EXEL
27.9 M $ 45.0 0.69 % $ 12.2 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands